TSIMCHI OFER

PrivateCIK: 2113635

TSIMCHI OFER enters REDHILL BIOPHARMA LTD. with 146.25M shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives
InsiderTSIMCHI OFERCIK 2113635
IssuerREDHILL BIOPHARMA LTD.CIK 1553846
Director
Since Mar 2026
146.25M
Baseline shares
100% direct
146.25M
Direct ownership
1 position
36.86M
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Ordinary Shares

Direct
Shares owned146.25M
Total
146.25M direct146.25M
Derivative Holdings4

Stock Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

150K

Shares owned

N/A

Exercise price

Expiration

Exercise window

American Depositary Shares

Direct
Underlying security
Ordinary Shares

Underlying shares

36.44M

Shares owned

N/A

Exercise price

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

90K

Shares owned

N/A

Exercise price

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

180K

Shares owned

N/A

Exercise price

Expiration

Exercise window

Total

Underlying

36.86M

Owned

0.00

TSIMCHI OFER — Initial Ownership Disclosure (Form 3) Filed Mar 19, 2026 | Finecho